Pill Politics : Drugs and the FDA /

From aspirin to Viagra to the latest cancer treatment, the Food and Drug Administration acts as a gatekeeper determining what medicines are legally available in the United States. But in fulfilling that regulatory role, Stephen Ceccoli argues, the FDA may inadvertently be promoting new drugs at the...

Descripción completa

Detalles Bibliográficos
Autor principal: Ceccoli, Stephen J. (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Boulder : Lynne Rienner Publishers, [2022]
Temas:
MEDICAL / Health Policy.
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000nam a22000005i 4500
001 DEGRUYTERUP_9781626374102
003 DE-B1597
005 20220629043637.0
006 m|||||o||d||||||||
007 cr || ||||||||
008 220629t20222004cou fo d z eng d
020 |a 9781626374102 
024 7 |a 10.1515/9781626374102  |2 doi 
035 |a (DE-B1597)623427 
040 |a DE-B1597  |b eng  |c DE-B1597  |e rda 
041 0 |a eng 
044 |a cou  |c US-CO 
072 7 |a MED036000  |2 bisacsh 
100 1 |a Ceccoli, Stephen J.,   |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Pill Politics :  |b Drugs and the FDA /  |c Stephen J. Ceccoli. 
264 1 |a Boulder :   |b Lynne Rienner Publishers,   |c [2022] 
264 4 |c ©2004 
300 |a 1 online resource (211 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 0 |t Frontmatter --   |t Contents --   |t Tables and Figures --   |t Acknowledgments --   |t 1. Putting the FDA into Perspective --   |t 2. The Politics of Assessing Drugs --   |t 3. An Evolving Regulatory Balance --   |t 4. The Drug Lag Debate and Demands for Reform --   |t 5. A Grand Compromise and the Shift to a New Era --   |t 6. Whither the FDA? --   |t 7. Protecting and Promoting Public Health in the United States --   |t Appendix: Drug Development and the FDA's Approval Process --   |t List of Abbreviations --   |t Notes --   |t Bibliography --   |t Index --   |t About the Book 
506 0 |a restricted access  |u http://purl.org/coar/access_right/c_16ec  |f online access with authorization  |2 star 
520 |a From aspirin to Viagra to the latest cancer treatment, the Food and Drug Administration acts as a gatekeeper determining what medicines are legally available in the United States. But in fulfilling that regulatory role, Stephen Ceccoli argues, the FDA may inadvertently be promoting new drugs at the expense of public health.The FDA's initial mandate to protect health grew out of pharmaceutical-related disasters in the early 1900s. Later criticisms that the agency's approach impeded industry competitiveness and failed to meet public need, however, led to a political compromise on its mission. The new FDA has cut its review time nearly in half and allows direct-to-consumer advertising, off-label promotion of drugs, and the "fast-tracking" of treatments. Ceccoli convincingly shows that this approval process, while redressing valid complaints, is also creating a new complex of problems that must be resolved. 
538 |a Mode of access: Internet via World Wide Web. 
546 |a In English. 
588 0 |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 29. Jun 2022) 
650 7 |a MEDICAL / Health Policy.  |2 bisacsh 
773 0 8 |i Title is part of eBook package:  |d De Gruyter  |t Lynne Rienner Press Complete eBook-Package 2013-2000  |z 9783110784251 
856 4 0 |u https://doi.uam.elogim.com/10.1515/9781626374102  |z Texto completo 
856 4 0 |u https://degruyter.uam.elogim.com/isbn/9781626374102  |z Texto completo 
912 |a 978-3-11-078425-1 Lynne Rienner Press Complete eBook-Package 2013-2000  |c 2000  |d 2013 
912 |a EBA_BACKALL 
912 |a EBA_CL_MDPM 
912 |a EBA_EBACKALL 
912 |a EBA_EBKALL 
912 |a EBA_ECL_MDPM 
912 |a EBA_EEBKALL 
912 |a EBA_ESTMALL 
912 |a EBA_PPALL 
912 |a EBA_STMALL 
912 |a GBV-deGruyter-alles 
912 |a PDA12STME 
912 |a PDA13ENGE 
912 |a PDA18STMEE 
912 |a PDA5EBK 

Ejemplares similares